Everything below concerns regulatory status. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-10-14. Where a claim depends on a specific study, the study is described rather than over-claimed.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Major agencies have not authorized it for therapeutic use. |
| Anti-doping status | Prohibited in sport | Listed among peptide hormones and related substances. |
| Primary research area | Metabolic and body-composition effects | Studies often examine fat mass or lipid markers. |
| Human evidence | Limited and mixed | Public data do not establish clinical efficacy. |
| Analytical detection | LC-MS and immunoassays | Methods vary in sensitivity and validation. |
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Before, I had avoided them like the plague, especially because of what they said about General Sharon and about Nicaragua. But nobody could say they were interested in oil in the Balkans, or in strategic needs, and the people who tried to say that – like Chomsky – looked ridiculous. So now I was interested. Hitchens argued that the choice in Yugoslavia was between a multi-ethnic plural democracy led by Muslim president Alija Izetbegović in Bosnia and a fascistic, nationalistically inspired ethnically cleansed state driven by Serbian leader Slobodan Milošević. He called Milošević a fascist and a "national-socialist", and condemned his war crimes in the Yugoslav Wars. In God Is Not Great, he wrote about Christian Orthodox Serbian and Roman Catholic Croatian nationalism- and religion-inspired crimes against the Muslim Bosniaks, at the hands of proponents of Serbian Chetnik revivalism, those in support of Croatian Ustashe revivalism and those for a Greater Serbia, during this period which are "often forgotten".
Aquaphor is a brand of over-the-counter (OTC) skin care ointments manufactured by Beiersdorf Inc., an affiliate of Beiersdorf AG. The brand was introduced in the United States in 1925. In accordance with the Food and Drug Administration's OTC Skin Protectant Monograph, Aquaphor contains 41 percent petrolatum (petroleum jelly) as its active ingredient. It is used to temporarily protect minor cuts, scrapes, and burns, as well as chapped or cracked skin. The product line includes ointments for compounding, general skin therapy, lip repair, and baby care. Aquaphor is used and recommended by health care professionals for minor post-operative wounds or defects.
"Sometimes Always", taken from Stoned & Dethroned, became the band's most commercially successful single in the US as it peaked at No. 96 on the Billboard Hot 100. The band departed from WEA after ten years, and then signed with Sub Pop Records in the US and re-signed with Creation Records in the UK for the release of the album Munki in 1998. The band broke up the following year as a result of an onstage altercation the year prior; William Reid prematurely left a tour after fighting with an intoxicated Jim Reid. They eventually reunited in 2007, and in 2017, they released Damage and Joy, their first studio album in 19 years and seventh overall. Their next album, Glasgow Eyes, was released in 2024 and became the band's first top 10 album in the UK since 1988.
=== Crime === Belize has moderate rates of violent crime. The majority of violence in Belize stems from gang activity, which includes trafficking of drugs and persons, protecting drug smuggling routes, and securing territory for drug dealing. In 2023, 87 murders were recorded in Belize, giving the country a homicide rate of 19.7 murders per 100,000 inhabitants, lower than the neighbouring countries of Mexico and Honduras, but higher than Guatemala and El Salvador. Belize District (containing Belize City) had the most murders by far compared to all the other districts. In 2023, 66% of the murders occurred in the Belize District. The violence in Belize City (especially the southern part of the city) is largely due to gang warfare. In 2023, there were 34 reported cases of rape, 170 robberies, 628 burglaries, and 118 cases of theft.
Sources: en.wikipedia.org
Remote Medical International (RMI) operates worldwide providing medical support services for companies and individuals operating in remote environments. RMI offers five main medical support services known as Core 5: RMI Staffing, RMI Topside Assistance, RMI Equipment & Supply, RMI Training, and RMI Consulting. The company serves clients in the energy sector, government and industrial services, military and law enforcement, executive protection, non-government organizations, and global logistics providers.
Such machines are used for freezing oocytes, skin, blood products, embryo, sperm, stem cells, and general tissue preservation in hospitals, veterinary practices, and research labs. The number of live births from 'slow frozen' embryos is some 300,000 to 400,000 or 20% of the estimated 3 million in vitro fertilized births. Dr Christopher Chen, Australia, reported the world’s first pregnancy using slow-frozen oocytes from a British controlled-rate freezer in 1986. Cryosurgery (intended and controlled tissue destruction by ice formation) was carried out by James Arnott in 1845 in an operation on a patient with cancer.
It was proposed to expand the list of the nine hallmarks of aging with five more. Saudi Arabia has started a not-for-profit organization called "the Hevolution Foundation" with budget $1 billion per year for developing anti-aging technology.
Sources: en.wikipedia.org
=== Fan works === The use of sandbox applications like Garry's Mod have allowed for Combine non-player characters to be used in a variety of webcomics and machinima productions. In one webcomic, Concerned, the Combine are portrayed as a highly bureaucratic and often inept organization. One issue shows a Civil Protection briefing for attempting to capture the comic's protagonist Gordon Frohman, in which officers are instructed to cluster around explosive barrels, seek cover on unstable structures and rappel down from bridges in front of fast moving vehicles. In another example, the machinima series Combine Nation follows Civil Protection officers in a similar style to police procedural documentaries. Other media portray the Combine with more serious overtones, such as the live-action video The Combine Interview, which parodies an interview with Tom Cruise discussing Scientology. The video, described by both Joystiq and Kotaku as "creepy", instead presents an interview with a Civil Protection officer discussing the Combine's rule of Earth, adapting Cruise's words to fit the Combine theme. PC Gamer UK noted that "the suggestion, of course, is that Scientology's purpose or self-image in some way resembles that of the homogenizing intergalactic murderous alien collective".
The analysis done based on satellite measurement data, estimates δD for the air in various parts of the world. The general trend is that δD is more negative at higher latitude, so air above Antarctica and the Arctic is D-depleted to around −230‰ to −260‰ or even lower. The estimated atmospheric δDs are shown on the map. A vast portion of global atmospheric water vapor comes from the Western Pacific near the tropics, (mean 2009) and the HIC of air depends on temperature and humidity. Hot, humid regions generally have higher δD. Water vapor in the air is in general more depleted than terrestrial water sources, since 1H216O evaporates faster than 1H2H16O due to higher vapor pressure. On the other hand, rain water is in general more enriched than atmospheric water vapor.
=== The socialist project === The political program developed by the governments presided by Felipe González was not a project of "socialist transformation" but of "modernization" of Spanish society to put it on a par with the rest of the "advanced" democratic societies. The PSOE's electoral program was very ambitious as it aimed to consolidate democracy and face the economic crisis as well as to adapt the productive structures to a more efficient and competitive economy and to achieve a fairer and more egalitarian society with the universalization of health, education and pensions. This was synthesized in the slogan "Que España funcione" ("Let Spain work") thanks to a "gobierno que gobierna" ("government that governs"). However, the economic and political situation that Calvo Sotelo's government bequeathed to him was very complicated. Economic stagnation continued, with unemployment exceeding 16%, inflation not falling below 15% and a runaway budget deficit. ETA activity continued and the threat of a coup had not disappeared.
Sources: en.wikipedia.org
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.
It is classified among peptide hormones and related substances that are prohibited in sport. The ban reflects anti-doping rules rather than a judgment that the peptide is effective for performance enhancement.
Human studies are limited and have not produced consistent evidence of meaningful clinical benefit. Some early trials examined metabolic endpoints, but larger confirmatory trials are generally lacking.
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.